GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Diasorin SpA (WBO:DIAS) » Definitions » Cyclically Adjusted PS Ratio

Diasorin SpA (WBO:DIAS) Cyclically Adjusted PS Ratio : 4.75 (As of May. 25, 2025)


View and export this data going back to 2020. Start your Free Trial

What is Diasorin SpA Cyclically Adjusted PS Ratio?

As of today (2025-05-25), Diasorin SpA's current share price is €89.70. Diasorin SpA's Cyclically Adjusted Revenue per Share for the quarter that ended in Mar. 2025 was €18.87. Diasorin SpA's Cyclically Adjusted PS Ratio for today is 4.75.

The historical rank and industry rank for Diasorin SpA's Cyclically Adjusted PS Ratio or its related term are showing as below:

WBO:DIAS' s Cyclically Adjusted PS Ratio Range Over the Past 10 Years
Min: 4.8   Med: 9.16   Max: 20.24
Current: 4.8

During the past years, Diasorin SpA's highest Cyclically Adjusted PS Ratio was 20.24. The lowest was 4.80. And the median was 9.16.

WBO:DIAS's Cyclically Adjusted PS Ratio is ranked worse than
73.48% of 132 companies
in the Medical Diagnostics & Research industry
Industry Median: 2.055 vs WBO:DIAS: 4.80

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted revenue per share of a company over the past 10 years.

Diasorin SpA's adjusted revenue per share data for the three months ended in Mar. 2025 was €5.808. Add all the adjusted revenue per share for the past 10 years together and divide 10 will get our Cyclically Adjusted Revenue per Share, which is €18.87 for the trailing ten years ended in Mar. 2025.

Shiller PE for Stocks: The True Measure of Stock Valuation


Diasorin SpA Cyclically Adjusted PS Ratio Historical Data

The historical data trend for Diasorin SpA's Cyclically Adjusted PS Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Diasorin SpA Cyclically Adjusted PS Ratio Chart

Diasorin SpA Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Cyclically Adjusted PS Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only 15.97 13.43 8.37 5.53 5.44

Diasorin SpA Quarterly Data
Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25
Cyclically Adjusted PS Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 5.19 5.28 5.83 5.44 4.87

Competitive Comparison of Diasorin SpA's Cyclically Adjusted PS Ratio

For the Diagnostics & Research subindustry, Diasorin SpA's Cyclically Adjusted PS Ratio, along with its competitors' market caps and Cyclically Adjusted PS Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Diasorin SpA's Cyclically Adjusted PS Ratio Distribution in the Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, Diasorin SpA's Cyclically Adjusted PS Ratio distribution charts can be found below:

* The bar in red indicates where Diasorin SpA's Cyclically Adjusted PS Ratio falls into.


;
;

Diasorin SpA Cyclically Adjusted PS Ratio Calculation

Like the Shiller PE Ratio, the Cyclically Adjusted PS Ratio takes the Revenue per Share from the past 10 years, adjusts it for inflation, and then calculates the average. This average is then used for the P/S calculation. Because it considers this 10-year average, it's often referred to as the CAPS Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio.

Diasorin SpA's Cyclically Adjusted PS Ratio for today is calculated as

Cyclically Adjusted PS Ratio=Share Price/ Cyclically Adjusted Revenue per Share
=89.70/18.87
=4.75

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Diasorin SpA's Cyclically Adjusted Revenue per Share for the quarter that ended in Mar. 2025 is calculated as:

For example, Diasorin SpA's adjusted Revenue per Share data for the three months ended in Mar. 2025 was:

Adj_RevenuePerShare=Revenue per Share/CPI of Mar. 2025 (Change)*Current CPI (Mar. 2025)
=5.808/122.5000*122.5000
=5.808

Current CPI (Mar. 2025) = 122.5000.

Diasorin SpA Quarterly Data

Revenue per Share CPI Adj_RevenuePerShare
201506 2.323 100.279 2.838
201509 2.236 100.000 2.739
201512 2.380 99.814 2.921
201603 2.265 99.600 2.786
201606 2.589 99.900 3.175
201609 2.685 100.100 3.286
201612 2.849 100.300 3.480
201703 2.876 101.000 3.488
201706 2.954 101.100 3.579
201709 2.728 101.200 3.302
201712 3.049 101.200 3.691
201803 2.969 101.800 3.573
201806 3.047 102.400 3.645
201809 2.976 102.600 3.553
201812 3.205 102.300 3.838
201903 3.125 102.800 3.724
201906 3.279 103.100 3.896
201909 3.194 102.900 3.802
201912 3.307 102.800 3.941
202003 3.187 102.900 3.794
202006 3.792 102.900 4.514
202009 4.161 102.300 4.983
202012 4.952 102.600 5.912
202103 4.870 103.700 5.753
202106 4.543 104.200 5.341
202109 6.270 104.900 7.322
202112 6.918 106.600 7.950
202203 6.536 110.400 7.252
202206 6.048 112.500 6.586
202209 6.074 114.200 6.515
202212 6.525 119.000 6.717
202303 5.419 118.800 5.588
202306 5.382 119.700 5.508
202309 5.067 120.300 5.160
202312 5.664 119.700 5.796
202403 5.416 120.200 5.520
202406 5.631 120.700 5.715
202409 5.383 121.200 5.441
202412 5.538 121.200 5.597
202503 5.808 122.500 5.808

Add all the adjusted revenue per share together and divide 10 will get our Cyclically Adjusted Revenue per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


Diasorin SpA  (WBO:DIAS) Cyclically Adjusted PS Ratio Explanation

Compared with the regular PS Ratio, which works poorly for cyclical businesses, the Cyclically Adjusted PS Ratio smoothed out the fluctuations of revenue during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Cyclically Adjusted PS Ratio should give similar results to regular PS Ratio.


Diasorin SpA Cyclically Adjusted PS Ratio Related Terms

Thank you for viewing the detailed overview of Diasorin SpA's Cyclically Adjusted PS Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Diasorin SpA Business Description

Traded in Other Exchanges
Address
Via Crescentino Snc, Saluggia, Vercelli, ITA, 13040
DiaSorin, headquartered in Italy, is a global provider of in vitro diagnostics, or IVD, which refers to testing done on samples taken from the human body, such as blood and tissue. DiaSorin produces and markets testing reagent kits for immunodiagnostics (about 65% of total sales) and molecular diagnostics (about 20%) and has a total installed base of about 9,000 diagnostic systems. Instruments and other revenue contribute about 15% of total sales. DiaSorin's largest market in 2023 was North America, which accounted for 48% of non-covid revenue, followed by Europe (35%) and the Rest of the World (18%).

Diasorin SpA Headlines

No Headlines